IL150488A0 - Use of pyrimidine endothelin antagonists in companion animals - Google Patents

Use of pyrimidine endothelin antagonists in companion animals

Info

Publication number
IL150488A0
IL150488A0 IL15048801A IL15048801A IL150488A0 IL 150488 A0 IL150488 A0 IL 150488A0 IL 15048801 A IL15048801 A IL 15048801A IL 15048801 A IL15048801 A IL 15048801A IL 150488 A0 IL150488 A0 IL 150488A0
Authority
IL
Israel
Prior art keywords
companion animals
pyrimidine
endothelin antagonists
endothelin
antagonists
Prior art date
Application number
IL15048801A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL150488A0 publication Critical patent/IL150488A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Chemical Treatment Of Metals (AREA)
IL15048801A 2000-02-11 2001-02-06 Use of pyrimidine endothelin antagonists in companion animals IL150488A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0003234.2A GB0003234D0 (en) 2000-02-11 2000-02-11 Method of treatment
PCT/IB2001/000142 WO2001058882A1 (en) 2000-02-11 2001-02-06 Use of pyrimidine endothelin antagonists in companion animals

Publications (1)

Publication Number Publication Date
IL150488A0 true IL150488A0 (en) 2002-12-01

Family

ID=9885465

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15048801A IL150488A0 (en) 2000-02-11 2001-02-06 Use of pyrimidine endothelin antagonists in companion animals

Country Status (17)

Country Link
EP (1) EP1254120B1 (xx)
JP (1) JP2003528050A (xx)
KR (1) KR20020075791A (xx)
AT (1) ATE271042T1 (xx)
AU (1) AU3043601A (xx)
CA (1) CA2398007A1 (xx)
DE (1) DE60104283T2 (xx)
DK (1) DK1254120T3 (xx)
ES (1) ES2222975T3 (xx)
GB (1) GB0003234D0 (xx)
HU (1) HUP0204370A3 (xx)
IL (1) IL150488A0 (xx)
NZ (1) NZ519002A (xx)
PT (1) PT1254120E (xx)
TR (1) TR200401815T4 (xx)
WO (1) WO2001058882A1 (xx)
ZA (1) ZA200206343B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8647660B2 (en) 2004-12-29 2014-02-11 Hill's Pet Nutrition, Inc. Combination of limited nutrients and enhanced dietary antioxidants to impart improved kidney health
US9272033B2 (en) 2005-04-19 2016-03-01 Hill's Pet Nutrition, Inc. Methods and compositions for the prevention and treatment of kidney disease
RU2573505C2 (ru) * 2010-02-25 2016-01-20 Ф.Хоффманн-Ля Рош Аг Способ определения константы связывания высокоаффинных соединений

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0882719B1 (en) * 1995-12-20 2001-05-16 Yamanouchi Pharmaceutical Co. Ltd. Arylethenesulfonamide derivatives and drug composition containing the same
WO1998057938A1 (fr) * 1997-06-19 1998-12-23 Yamanouchi Pharmaceutical Co., Ltd. Derives d'alcanesulfonamide inferieur substitue et composition pharmaceutique les contenant

Also Published As

Publication number Publication date
EP1254120A1 (en) 2002-11-06
ES2222975T3 (es) 2005-02-16
ZA200206343B (en) 2003-08-08
HUP0204370A3 (en) 2003-07-28
GB0003234D0 (en) 2000-04-05
DE60104283D1 (de) 2004-08-19
DE60104283T2 (de) 2004-11-18
DK1254120T3 (da) 2004-10-04
PT1254120E (pt) 2004-10-29
EP1254120B1 (en) 2004-07-14
TR200401815T4 (tr) 2004-08-23
WO2001058882A1 (en) 2001-08-16
ATE271042T1 (de) 2004-07-15
KR20020075791A (ko) 2002-10-05
NZ519002A (en) 2004-06-25
JP2003528050A (ja) 2003-09-24
CA2398007A1 (en) 2001-08-16
HUP0204370A2 (en) 2003-05-28
AU3043601A (en) 2001-08-20

Similar Documents

Publication Publication Date Title
MX261332B (es) Uso de proteasas estables en acido para alimento de animales.
ID28812A (id) Enzima-enzima antimikroba di dalam pakan hewan
TR200102839T2 (tr) LH agonistleri olarak faydalı bisiklik heteroaromatik bileşikler.
PL369024A1 (en) Arthropodicidal anthranilamides
AU2003217974A8 (en) Hoofed animal pad
NO20015176L (no) Anvendelse av kreatin som fortilsats
AU149714S (en) Animal puppy chew
YU82503A (sh) Upotreba antagonista neuronskih natrijumovih kanala za kontrolu ektoparazita kod toplokrvnih životinja
MY136297A (en) Piperazine derivatives having sst1 antagonistic activity
IL150488A0 (en) Use of pyrimidine endothelin antagonists in companion animals
ATE287403T1 (de) 6-phenylbenzonaphthyidine
MXPA03008681A (es) (oxo-pirazol[1,5]pirimidin-2-il)alquil-carboxamidas.
WO2000075119A3 (de) Substituierte 2-aryl-1,2,4-triazin-3,5-di(thi)one als herbizide
LU90560B1 (fr) B-timent d'-levage d'animaux - ventelles
AU2000251168A1 (en) Feed additives, forage and agents for animals, methods for the use thereof
ITFR20030020A1 (it) Miscela di sostanze naturali destinata all'alimentazione degli animali di allevamento.
ES1043194Y (es) Comedero para la 1 edad de animales estabulados.
RU2002135882A (ru) Кормовая добавка для молодняка крупного рогатого скота
RU2002102828A (ru) Этиловый эфир 5-бром-3,4-дигидрокси-2-карбамоил-6-оксо-6-фенил-2,4-гексадиеновой кислоты, проявляющий антимикробную активность
IT1318718B1 (it) Batteria per l'allevamento di avicoli o di altri animali daallevamento
Shipilov et al. Tectonic and geodynamic evolution of the Lomonosov ridge
RU2001105594A (ru) Кормовая добавка
ATE332647T1 (de) Verwendung von quillaja-pulver
ES1051402Y (es) Recogedor de excrementos de animales.
RU97103767A (ru) 5-нитрофурфурилиденгидразид 2-хлор-5,6,7,8-тетрагидрохинолин-4-карбоновой кислоты, проявляющий антимикробную активность